Pharmacy benefit managers (PBMs) significantly impact GTN revenue through rebates, but patient access issues persist due to ...
At a time when investors are questioning the sustainability of pharmaceutical business models, reliable execution has become a direct lever for profitability and growth. AI-powered control towers and ...
Screen: Pro-ficiency creates clinical trial simulations, filling a gap for the Simulations Plus suite of products. So far, 2024 is shaping up to be a banner year for Simulations Plus Inc. The ...
Market conditions remain tough, which is weighing on demand for both Schrödinger's software and drug discovery services. Investors continue to punish Schrödinger's investments in drug discovery, ...
Biotech innovator accelerated growth in 2025, doubled headcount, and expanded operations in the US The Cradle platform provides AI protein design tools trained on unique customer data and tailored for ...
QPR SOFTWARE PLC PRESS RELEASE 17 December 2025 at 11:00 a.m. EETQPR Software Plc has signed a three-year extension agreement with one of the world's leading pharmaceutical companies. The ...
Artificial intelligence draws a lot of attention for its role in drug discovery, where it’s intended to speed up the process of identifying targets and the molecules that can drug them. But that’s ...
The pharmaceutical industry is the cornerstone of drug development, commercialization and marketing. According to Statista, pharma sector revenues topped US$1 trillion for the first time in 2014, and ...
Pharmaceutical giants such as J&J, Merck, and Eli Lilly are embracing AI and prioritizing upskilling. They hope that training thousands of employees on generative AI will boost productivity in drug ...
Pharmaceutical and biotech companies have seen a shrinking share of investments across the five boroughs in the first half of 2025 as software startups suck up more of the city’s venture capital. More ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results